Macroscope

As investors debate whether China is ‘uninvestable’, policy pivots to economic growth

Did investors panic after China’s Party Congress in October? It certainly looks so. Both the Hong Kong stock exchange and Chinese high yield credit are up by a third in the seven weeks since the meeting, and the market narrative has shifted at extraordinary speed in at least three ways, according to Strategist Sahil Mahtani.

13 Dec 2022

2 minutes

Sahil Mahtani
Listen to this article

0:00
0:00

13 December 2022, First, investors were expecting policymakers to continue with China’s draconian zero-Covid policy. Instead, policymakers pivoted. In mid-November, they announced a 20-point plan to soften quarantine and testing requirements. After protests against Covid restrictions erupted in major cities, policymakers responded on December 7th with a further easing of quarantine and testing requirements.

Second, investors were expecting policymakers to keep up the pressure on the private sector that began at the December 2020 Politburo meeting. There, terms like “anti-monopoly” and “curbing the disorderly expansion of capital” first entered market consciousness. Instead, in the December 2022 Politburo statement, policymakers stressed “two unwaverings”. These were unwavering support for the public sector and unwavering support for the private sector, language last mentioned in the halcyon days of 2018.

Third, Chinese policymakers made it clear in the December 2022 statement that their policy priorities for 2023 were about “significantly boosting market confidence” and “expanding domestic demand.” To some extent that direction of travel was already evident in the 16-point plan announced mid-November to stabilise the property sector.

To be fair, stabilising growth was always the plan for 2022 before it was so firmly interrupted by Omicron and its subsequent variants. This can be juxtaposed against 2021 which was deemed a “window of opportunity” to address challenging structural imbalances created by the strong external demand environment; and the July 2022 statement that focused on Covid (“people first, life first”). This time growth is the focus.

Thus, the policy shift is now quite clear. Predictably, it came just as investors had started debating whether China was “uninvestable,” whatever that means.

What is the outlook for the coming year? There is obviously uncertainty about zero-Covid, about the property market, and the extent of the coming stimulus. The latter is, in part, a continuation of monetary and credit easing that has been ongoing all year. And, as in the West, reopening is unlikely to proceed in a straight line. As our experience shows, Covid waves are possible and perhaps likely. But just as the November vaccine discovery in 2020 was an important driver of the DM market rally, despite two subsequent Covid waves, so China’s decision to end the lockdowns and doubling down on economic stimulus could be key, whatever happens next.

Authored by

Sahil Mahtani
Strategist, Investment Institute

Important Information

The information may discuss general market activity or industry trends and is not intended to be relied upon as a forecast, research or investment advice. The economic and market views presented herein reflect Ninety One’s judgment as at the date shown and are subject to change without notice. There is no guarantee that views and opinions expressed will be correct and may not reflect those of Ninety One as a whole, different views may be expressed based on different investment objectives. Although we believe any information obtained from external sources to be reliable, we have not independently verified it, and we cannot guarantee its accuracy or completeness. Ninety One’s internal data may not be audited. Ninety One does not provide legal or tax advice. Prospective investors should consult their tax advisors before making tax-related investment decisions.

This communication is provided for general information only and is not an invitation to make an investment nor does it constitute an offer for sale. Investment involves risks. This is not a recommendation to buy, sell or hold a particular security. No representation is being made that any investment will or is likely to achieve profits or losses similar to those achieved in the past, or that significant losses will be avoided. The securities or investment products mentioned in this document may not have been registered in any jurisdiction.

In Hong Kong, this communication is issued by Ninety One Hong Kong Limited and has not been reviewed by the Securities and Futures Commission (SFC).

Except as otherwise authorised, this information may not be shown, copied, transmitted, or otherwise given to any third party without Ninety One’s prior written consent. © 2025 Ninety One. All rights reserved.

Past performance figures shown are not indicative of future performance. Investors are reminded that investment involves risk. Investors should refer to the offering documents for details, including risk factors. This website has not been reviewed by the SFC. 

By clicking on the hyperlink of Investor relations below, you are leaving this website with information specific for retail investors in Hong Kong and entering the global website.

Please note that the global website is not intended to target Hong Kong investors. It has not been reviewed by the Hong Kong Securities and Futures Commission (“SFC”). The website may contain information on funds and other investments products that are not authorised by the SFC and therefore are not available to retail investors in Hong Kong. The website may also contain information on investment services / strategies that are purported to be carried out by a Ninety One group company outside of Hong Kong.

Any product documents and information contained in this website are for reference only and for those persons or entities in any jurisdictions or country where the information and use thereof is not contrary to local law or regulation.

Issuer: Ninety One Hong Kong Limited
Email: [email protected] 
Telephone: (852) 2861 6888 
Fax: (852) 2861 6861